Literature DB >> 21337348

High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population.

Ako Fukami1, Sho-ichi Yamagishi, Hisashi Adachi, Takanori Matsui, Kuniko Yoshikawa, Kinuka Ogata, Akiko Kasahara, Eri Tsukagawa, Kanako Yokoi, Tsutomu Imaizumi.   

Abstract

BACKGROUND: Monocyte chemoattractant protein-1 (MCP-1) plays a role in cardiovascular disease (CVD) and renal injury. Recent clinical studies have suggested that circulating levels of MCP-1 could be a biomarker of atherosclerosis and future cardiovascular events in humans. Because chronic kidney disease (CKD) is one of the risk factors of CVD, it is conceivable that elevated MCP-1 levels may link the increased risk of CVD in CKD patients. However, as far as we know, in addition to well-known traditional risk factors for atherosclerosis, whether renal dysfunction could be independently associated with the elevation of MCP-1 levels in a general population remains unknown. Therefore, we examined here which anthropometric and metabolic variables, including renal function, could be independent correlates of circulating levels of MCP-1 in a general population. HYPOTHESIS: We hypothesized that renal function was one of the independent correlates of serum MCP-1 levels.
METHODS: A total of 860 Japanese residents (318 males and 542 females, mean age 65.4 ± 9.8 years) in a small fishing community underwent a complete history and physical examination with determination of blood chemistries, including serum levels of MCP-1.
RESULTS: Mean MCP-1 levels were 281.4 pg/mL. Multiple stepwise regression analyses revealed that male sex (P<0.0001), age (P=0.03), estimated glomerular filtration rate (eGFR) (P<0.0001, inversely), and white blood cell count (P=0.037) were independently associated with MCP-1 levels.
CONCLUSIONS: The present study demonstrated for the first time that other than white blood cell count, eGFR was an independent correlate of serum levels of MCP-1 in a Japanese general population. Elevated MCP-1 levels may partly explain the increased risk of CVD in CKD patients.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21337348      PMCID: PMC6652339          DOI: 10.1002/clc.20834

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  10 in total

1.  Cardio-ankle vascular index is linked to deranged metabolic status, especially high HbA1c and monocyte-chemoattractant-1 protein, in predialysis chronic kidney disease.

Authors:  Mehmet Mert; Belda Dursun; Ahmet Baki Yağcı; Ayşen Çetin Kardeşler; Hande Şenol; Süleyman Demir
Journal:  Int Urol Nephrol       Date:  2019-11-26       Impact factor: 2.370

2.  Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.

Authors:  L Parker Gregg; Maria Clarissa Tio; Xilong Li; Beverley Adams-Huet; James A de Lemos; S Susan Hedayati
Journal:  Am J Nephrol       Date:  2018-06-06       Impact factor: 3.754

3.  Association of adipokines with cardiovascular risk factors in low birth weight children: a case-control study.

Authors:  Maria Wany Louzada Strufaldi; Rosana Fiorini Puccini; Olga Maria Amâncio Silvério; Maria Carmo do Pinho Franco
Journal:  Eur J Pediatr       Date:  2012-09-27       Impact factor: 3.183

Review 4.  Cardiovascular Disease in Adults with Type 1 Diabetes: Looking Beyond Glycemic Control.

Authors:  Rachel G Miller; Tina Costacou
Journal:  Curr Cardiol Rep       Date:  2022-08-10       Impact factor: 3.955

Review 5.  Association between MCP-1 2518 A>G gene polymorphism and chronic kidney disease.

Authors:  Song Mao; Liangxia Wu
Journal:  Int Urol Nephrol       Date:  2018-08-14       Impact factor: 2.370

6.  Is the inflammasome a potential therapeutic target in renal disease?

Authors:  Clare M Turner; Nishkantha Arulkumaran; Mervyn Singer; Robert J Unwin; Frederick W K Tam
Journal:  BMC Nephrol       Date:  2014-01-23       Impact factor: 2.388

Review 7.  Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome.

Authors:  Simona Mihai; Elena Codrici; Ionela Daniela Popescu; Ana-Maria Enciu; Lucian Albulescu; Laura Georgiana Necula; Cristina Mambet; Gabriela Anton; Cristiana Tanase
Journal:  J Immunol Res       Date:  2018-09-06       Impact factor: 4.818

8.  25-vitamin D reduces inflammation in uremic environment.

Authors:  Rodrigo Barbosa de Oliveira Brito; Jacqueline Ferritto Rebello; Caren Cristina Grabulosa; Walter Pinto; Armando Morales; Rosilene Motta Elias; Rosa Maria Affonso Moyses; Maria Aparecida Dalboni
Journal:  Sci Rep       Date:  2020-01-10       Impact factor: 4.379

9.  Involvement of chronic inflammation via monocyte chemoattractant protein-1 in uraemic cardiomyopathy: a human biopsy study.

Authors:  Tomoya Nakano; Kenji Onoue; Ayako Seno; Satomi Ishihara; Yasuki Nakada; Hitoshi Nakagawa; Tomoya Ueda; Taku Nishida; Tsunenari Soeda; Makoto Watanabe; Rika Kawakami; Kinta Hatakeyama; Yasuhiro Sakaguchi; Chiho Ohbayashi; Yoshihiko Saito
Journal:  ESC Heart Fail       Date:  2021-05-14

10.  Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients.

Authors:  Isabella Viana Gomes Schettini; Débora Vargas Faria; Leilismara Sousa Nogueira; Alba Otoni; Ana Cristina Simões E Silva; Danyelle Romana Alves Rios
Journal:  J Bras Nefrol       Date:  2022 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.